SOHM (SHMN) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 25, 2026)


What is SOHM Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

SOHM's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

SHMN vs NUVPF, ADMD, RSPI: Margin of Safety % (DCF Earnings Based) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, SOHM's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SOHM Margin of Safety % (DCF Earnings Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, SOHM's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where SOHM's Margin of Safety % (DCF Earnings Based) falls into.


SOHM Business Description

Address 4195 Chino Hills Parkway, Suite 675, Chino Hills, CA, USA, 91709
SOHM Inc is a pharmaceutical, cosmeceutical, nutraceutical and biotech manufacturer that produces and markets generic drugs and products for various treatment categories. The products of the company include OTC and RX: Generic CDMO Services, and ABBIE Systems. The organization markets and sells its generic drugs globally but focuses on emerging markets in Africa, Latin America, Southeast Asia, and others.